Cell Death and Disease (Oct 2023)

Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress

  • Bai Cui,
  • Bin He,
  • Yanping Huang,
  • Cenxin Wang,
  • Huandong Luo,
  • Jinxin Lu,
  • Keyu Su,
  • Xiaoyu Zhang,
  • Yuanyuan Luo,
  • Zhuoran Zhao,
  • Yuqing Yang,
  • Yunkun Zhang,
  • Fan An,
  • Hong Wang,
  • Eric W.-F. Lam,
  • Keith W. Kelley,
  • Ling Wang,
  • Quentin Liu,
  • Fei Peng

DOI
https://doi.org/10.1038/s41419-023-06200-5
Journal volume & issue
Vol. 14, no. 10
pp. 1 – 16

Abstract

Read online

Abstract Cancer stem-like cells (CSCs) contribute to cancer metastasis, drug resistance and tumor relapse, yet how amino acid metabolism promotes CSC maintenance remains exclusive. Here, we identify that proline synthetase PYCR1 is critical for breast cancer stemness and tumor growth. Mechanistically, PYCR1-synthesized proline activates cGMP-PKG signaling to enhance cancer stem-like traits. Importantly, cGMP-PKG signaling mediates psychological stress-induced cancer stem-like phenotypes and tumorigenesis. Ablation of PYCR1 markedly reverses psychological stress-induced proline synthesis, cGMP-PKG signaling activation and cancer progression. Clinically, PYCR1 and cGMP-PKG signaling components are highly expressed in breast tumor specimens, conferring poor survival in breast cancer patients. Targeting proline metabolism or cGMP-PKG signaling pathway provides a potential therapeutic strategy for breast patients undergoing psychological stress. Collectively, our findings unveil that PYCR1-enhanced proline synthesis displays a critical role in maintaining breast cancer stemness.